KalshiTechOpenUpdated May 16, 2026
When will the FDA approve Compass Pathways' COMP360 Psilocybin?
5 markets · 7mo
✨ Ask about this eventMarkets in this event
Kalshi
Open
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027? — Before Mar 1, 2027
Yes59¢
No41¢
Yes ≈ 59% chance
$1.1K Vol7mo
Kalshi
Open
Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Jan 1, 2027? — Before Jan 1, 2027
Yes34¢
No66¢
Yes ≈ 34% chance
$2K Vol5mo
Kalshi
Open
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? — Before 2028
Yes82¢
No18¢
Yes ≈ 82% chance
$786 Vol1y
Kalshi
Open
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? — Before October 2027
Yes90¢
No10¢
Yes ≈ 90% chance
$2.3K Vol1y
Kalshi
Open
When will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression? — Before July 2027
Yes79¢
No21¢
Yes ≈ 79% chance
$8.6K Vol11mo
Data from Kalshi’s public API, for informational purposes only. PredictPal is not affiliated with any platform and does not facilitate trading.
Discussion
optional stance
Loading…